These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6778378)

  • 1. Antimycoplasmal activity of dimethylphenols in a tracheal explant culture system.
    Agee CC; Engelhardt JA; Gabridge MG
    Antimicrob Agents Chemother; 1980 Aug; 18(2):243-8. PubMed ID: 6778378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cell-associated pathogen metabolism in infection of tracheal explants by Mycoplasma pneumoniae.
    Gabridge MG; Dee Barden Stahl Y
    Med Microbiol Immunol; 1978 Oct; 165(3):153-61. PubMed ID: 569248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterization of the in vitro and in vivo activity of ciprofloxacin against mycoplasmas.
    Furneri PM; Tempera G; Chiarenza A; Caccamo F; Speciale AM; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):346-9. PubMed ID: 3123079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adenine in pathogenesis of Mycoplasma pneumoniae infections of tracheal epithelium.
    Gabridge MG; Stahl YD
    Med Microbiol Immunol; 1978 May; 165(1):43-55. PubMed ID: 566372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children.
    Yuan C; Min FM; Ling YJ; Li G; Ye HZ; Pan JH; Wang L; Xie YP
    Comb Chem High Throughput Screen; 2018; 21(10):749-754. PubMed ID: 30636596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attachment of Mycoplasma pneumoniae to tracheal monolayer outgrowths.
    Gabridge MG
    Yale J Biol Med; 1983; 56(5-6):657-63. PubMed ID: 6433577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the morphological and biochemical features of the attachment process in infections with Mycoplasma pneumoniae.
    Gabridge MG
    Rev Infect Dis; 1982; 4 Suppl():S179-84. PubMed ID: 6812201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.
    Ishida K; Kaku M; Irifune K; Mizukane R; Takemura H; Yoshida R; Tanaka H; Usui T; Suyama N; Tomono K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):790-8. PubMed ID: 8031048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae.
    Kaku M; Ishida K; Irifune K; Mizukane R; Takemura H; Yoshida R; Tanaka H; Usui T; Tomono K; Suyama N
    Antimicrob Agents Chemother; 1994 Apr; 38(4):738-41. PubMed ID: 8031039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of organ cultures and animal models in the study of Mycoplasma pneumoniae infections.
    Taylor-Robinson D
    Infection; 1976; 4(1 Suppl):4-8. PubMed ID: 783047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoplasma pneumoniae in hamster tracheal organ culture studied by scanning electron microscopy.
    Muse KE; Powell DA; Collier AM
    Infect Immun; 1976 Jan; 13(1):229-37. PubMed ID: 1248872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciliostatic, hemagglutinating, and proteolytic activities in a cell extract of Mycoplasma pneumoniae.
    Chandler DK; Barile MF
    Infect Immun; 1980 Sep; 29(3):1111-6. PubMed ID: 6776059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis on antibacterial activity of common antibiotics to Mycoplasma pneumoniae].
    Xin DL; Chen XG; Han X
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):305-6. PubMed ID: 19555573
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of oxytetracycline and erythromycin on Syrian hamsters after intratracheal infection with Mycoplasma pneumoniae.
    Ritter E; Lange A; Rockel C; Ortel J
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):83-9. PubMed ID: 3106470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae.
    Hsieh YC; Tsao KC; Huang CG; Tong S; Winchell JM; Huang YC; Shia SH; Lai SH; Lin TY
    Pediatr Infect Dis J; 2012 Feb; 31(2):208-9. PubMed ID: 21941216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Lee H; Yun KW; Lee HJ; Choi EH
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory tract organ cultures to assay attachment and pathogenicity of mycoplasmas.
    Gabridge MG
    Ann Microbiol (Paris); 1984; 135A(1):33-8. PubMed ID: 6424525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.
    Pereyre S; de Barbeyrac B; Renaudin H; Poutiers F; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2001 Feb; 47(2):240-1. PubMed ID: 11157917
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimycoplasmal activity of hydroxytyrosol.
    Furneri PM; Piperno A; Sajia A; Bisignano G
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4892-4. PubMed ID: 15561875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural observations on cellular and subcellular aspects of experimental Mycoplasma pneumoniae disease.
    Carson JL; Collier AM; Hu SC
    Infect Immun; 1980 Sep; 29(3):1117-24. PubMed ID: 6776060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.